A Study to Identify Predictors of Response to Duloxetine in Breast Cancer Patients With Chronic Pain
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Duloxetine (Primary)
- Indications Pain
- Focus Therapeutic Use
- 03 Feb 2017 Planned End Date changed from 1 Jul 2017 to 1 Mar 2023.
- 03 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2019.
- 24 Dec 2014 The study design (crossover, randomized, double-blind to open-label, single group), primary endpoint and number of treatment arms (from 2 to 1) have been changed as reported by ClinicalTrials.gov record.